Home › Funds › DUPONT CAPITAL MANAGEMENT CORP › OCS
DUPONT CAPITAL MANAGEMENT CORP position in OCS
OCULIS HOLDING AG · Health Care
DUPONT CAPITAL MANAGEMENT CORP reported holding 4 shares of OCS (OCULIS HOLDING AG) in its Q3 2026 13F filing — a position valued at US$37K, representing 0.00% of its reported portfolio and ranking #33 among its reported holdings. DUPONT CAPITAL MANAGEMENT CORP has disclosed OCS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How DUPONT CAPITAL MANAGEMENT CORP's OCS position evolved
DUPONT CAPITAL MANAGEMENT CORP first disclosed a stake in OCS in Q3 2023 at 4 shares (US$0K). The position peaked in Q2 2026 at 4 shares, worth US$55K. Across 13 filings, DUPONT CAPITAL MANAGEMENT CORP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 4 shares valued at US$37K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 4 | $45 | New |
| Q4 2023 | 4 | $44 | Hold |
| Q1 2024 | 4 | $48 | Hold |
| Q2 2024 | 4 | $48 | Hold |
| Q3 2024 | 4 | $49 | Hold |
| Q4 2024 | 4 | $68 | Hold |
| Q1 2025 | 4 | $76 | Hold |
| Q2 2025 | 4 | $78 | Hold |
| Q3 2025 | 4 | $71 | Hold |
| Q4 2025 | 4 | $80 | Hold |
| Q1 2026 | 4 | $106 | Hold |
| Q2 2026 | 4 | $55.00K | Hold |
| Q3 2026 | 4 | $37.00K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About OCS and 13F data
OCS (OCULIS HOLDING AG) is a Health Care company. 65 other funds we track also report a position in OCS — the largest reported positions include EQT Fund Management S.a r.l. (US$64.9M), Gildi - lifeyrissjodur (US$64.3M), Pivotal bioVenture Partners Investment Advisor LLC (US$20.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding OCS
- EQT Fund Management S.a r.l. 6.95M sh · $64.92M · Q3 2026
- Gildi - lifeyrissjodur 2.43M sh · $64.32M · Q1 2026
- Pivotal bioVenture Partners Investment Advisor LLC 1.51M sh · $20.89M · Q2 2026
- Saturn V Capital Management LP 684.88K sh · $9.50M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 641.02K sh · $8.89M · Q2 2026
- Nan Fung Group Holdings Ltd 300.56K sh · $4.17M · Q2 2026
- SYQUANT CAPITAL SAS 375.00K sh · $2.82M · Q3 2026
- Marble Bar Asset Management LLP 14.81K sh · $205.36K · Q2 2026
More on DUPONT CAPITAL MANAGEMENT CORP
FAQ
How long has DUPONT CAPITAL MANAGEMENT CORP held OCS?
DUPONT CAPITAL MANAGEMENT CORP has disclosed OCS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is DUPONT CAPITAL MANAGEMENT CORP's current position in OCS?
As of Q3 2026, DUPONT CAPITAL MANAGEMENT CORP holds 4 shares of OCS (OCULIS HOLDING AG), valued at $37.00K, representing 0.00% of its reported portfolio and ranking #33.
Has DUPONT CAPITAL MANAGEMENT CORP been buying or selling OCS?
In the latest 13F filing (Q3 2026), DUPONT CAPITAL MANAGEMENT CORP held unchanged its position in OCS. The position peaked in Q2 2026 at 4 shares.
Which other funds hold OCS?
Other major institutional holders of OCS include EQT Fund Management S.a r.l., Gildi - lifeyrissjodur, Pivotal bioVenture Partners Investment Advisor LLC, among 65 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.